Baijin Life Science Holdings Limited
MNNGF
$0.08
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -191.99% | -496.02% | -186.16% | -163.73% | -142.54% |
| Total Depreciation and Amortization | 260.98% | 147.45% | 35.62% | 16.01% | -3.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -60.94% | 22.69% | 39.54% | 58.82% | 78.99% |
| Change in Net Operating Assets | 72.30% | 454.19% | 1,166.07% | 40.22% | -125.60% |
| Cash from Operations | -29.70% | 35.85% | 69.92% | 40.17% | -40.22% |
| Capital Expenditure | -2,000.00% | -1,285.29% | -573.53% | -186.96% | 42.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -96.54% | -96.40% | -96.25% | 5.46% | 459,890.00% |
| Cash from Investing | -88.08% | -87.32% | -86.55% | 15.38% | 62,214.86% |
| Total Debt Issued | 125.23% | 79.48% | 10.85% | 158.27% | 14,900.00% |
| Total Debt Repaid | 78.86% | 93.88% | 96.31% | 89.90% | 83.25% |
| Issuance of Common Stock | -- | -62.08% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 9.78% | -822.78% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -115.96% | -123.34% | -279.10% | 173.68% | 180.36% |
| Cash from Financing | 2,563.61% | 557.58% | -77.76% | -98.28% | -282.67% |
| Foreign Exchange rate Adjustments | -4,450.00% | -9,100.00% | -1,363.75% | -585.54% | 80.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -86.84% | -100.58% | -119.12% | 115.82% | 391.94% |